KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Cost of Revenue (2016 - 2026)

Johnson & Johnson's Cost of Revenue history spans 18 years, with the latest figure at $8.1 billion for Q1 2026.

  • On a quarterly basis, Cost of Revenue rose 10.18% to $8.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $31.0 billion, a 9.49% increase, with the full-year FY2025 number at $30.3 billion, up 10.14% from a year prior.
  • Cost of Revenue hit $8.1 billion in Q1 2026 for Johnson & Johnson, up from $8.0 billion in the prior quarter.
  • Over the last five years, Cost of Revenue for JNJ hit a ceiling of $8.1 billion in Q1 2026 and a floor of $2.7 billion in Q1 2023.
  • Historically, Cost of Revenue has averaged $6.9 billion across 5 years, with a median of $7.0 billion in 2024.
  • The widest YoY moves for Cost of Revenue: up 152.15% in 2023, down 18.4% in 2023.
  • Tracing JNJ's Cost of Revenue over 5 years: stood at $6.2 billion in 2022, then rose by 10.14% to $6.8 billion in 2023, then increased by 4.85% to $7.1 billion in 2024, then rose by 11.78% to $8.0 billion in 2025, then increased by 1.73% to $8.1 billion in 2026.
  • Business Quant data shows Cost of Revenue for JNJ at $8.1 billion in Q1 2026, $8.0 billion in Q4 2025, and $7.3 billion in Q3 2025.